PAPER Lee GJ, Lu PH, Hua X, Lee S, Wu S, Nguyen K, Teng E, Leow AD, Jack CR, Toga AW, Weiner MW, Bartzokis G, Thompson PM,
SEARCH RESULTS
330059 RESULTS
PAPER Kossoff EH, Hartman AL
Ketogenic diets: new advances for metabolism-based therapies.
Curr Opin Neurol. 2012 Apr;25(2):173-8. PubMed: 22322415PAPER Li J, Liu B, Gao X, Ma Z, Caosong T, Mei YA, Zheng Y
Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.
Protein Cell. 2012 Feb;3(2):153-9. PubMed: 22322890PAPER Liu T, Bitan G
Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
ChemMedChem. 2012 Mar 5;7(3):359-74. PubMed: 22323134PAPER Bellassen V, Iglói K, de Souza LC, Dubois B, Rondi-Reig L
Temporal order memory assessed during spatiotemporal navigation as a behavioral cognitive marker for differential Alzheimer's disease diagnosis.
J Neurosci. 2012 Feb 8;32(6):1942-52. PubMed: 22323707PAPER Allard S, Leon WC, Pakavathkumar P, Bruno MA, Ribeiro-da-Silva A, Cuello AC
Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype.
J Neurosci. 2012 Feb 8;32(6):2002-12. PubMed: 22323714PAPER Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y, Ni K, Matsuoka N
Differential effects between γ-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice.
J Neurosci. 2012 Feb 8;32(6):2037-50. PubMed: 22323718PAPER Ryu HG, Youn SW, Kwon OD
Lack of Association between Apolipoprotein E Polymorphism with Age at Onset of Subcortical Vascular Dementia.
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):1-9. PubMed: 22323902PAPER Smach MA, Edziri H, Charfeddine B, Ben Othman L, Lammouchi T, Ltaief A, Nafati S, Dridi H, Bennamou S, Limem K
Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease.
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):249-57. PubMed: 22323901PAPER Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE
ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
Science. 2012 Mar 23;335(6075):1503-6. Epub 2012 Feb 9 PubMed: 22323736PAPER Uematsu M, Adachi E, Nakamura A, Tsuchiya K, Uchihara T
Atomic identification of fluorescent Q-dots on tau-positive fibrils in 3D-reconstructed pick bodies.
Am J Pathol. 2012 Apr;180(4):1394-7. PubMed: 22322305PAPER Perret-Liaudet A, Pelpel M, Tholance Y, Dumont B, Vanderstichele H, Zorzi W, Elmoualij B, Schraen S, Moreaud O, Gabelle A, Thouvenot E, Thomas-Anterion C, Touchon J, Krolak-Salmon P, Kovacs GG, Coudreuse A, Quadrio I, Lehmann S
Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis.
Clin Chem. 2012 Apr;58(4):787-9. PubMed: 22322825PAPER Isik AT, Bozoglu E, Eker D
aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.
J Nutr Health Aging. 2012 Feb;16(2):139-41. PubMed: 22323348PAPER Gonfrier S, Andrieu S, Renaud D, Vellas B, Robert PH
Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort.
J Nutr Health Aging. 2012 Feb;16(2):134-7. PubMed: 22323347PAPER Watabe-Rudolph M, Song Z, Lausser L, Schnack C, Begus-Nahrmann Y, Scheithauer MO, Rettinger G, Otto M, Tumani H, Thal DR, Attems J, Jellinger KA, Kestler HA, von Arnim CA, Rudolph KL
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease.
Neurology. 2012 Feb 21;78(8):569-77. PubMed: 22323746Current Filters
No filters selected